carteolol has been researched along with Respiration Disorders in 1 studies
Carteolol: A beta-adrenergic antagonist used as an anti-arrhythmia agent, an anti-angina agent, an antihypertensive agent, and an antiglaucoma agent.
Respiration Disorders: Diseases of the respiratory system in general or unspecified or for a specific respiratory disease not available.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yamada, Y | 1 |
| Takayanagi, R | 1 |
| Tsuchiya, K | 1 |
| Ito, K | 1 |
| Ohtani, H | 1 |
| Sawada, Y | 1 |
| Iga, T | 1 |
1 other study available for carteolol and Respiration Disorders
| Article | Year |
|---|---|
Assessment of systemic adverse reactions induced by ophthalmic beta-adrenergic receptor antagonists.
Topics: Administration, Oral; Administration, Topical; Adrenergic beta-Antagonists; Betaxolol; Cardiovascula | 2001 |